JANUMET XR 1000 mg/1

Janumet XR 1000 mg/1 combines sitagliptin and metformin hydrochloride in extended-release tablets for oral use. This medication is designed to help manage certain health conditions by targeting blood sugar levels. It is a prescription-only product from Merck Sharp & Dohme LLC.

Janumet XR 1000 mg/1 is typically used as part of a treatment plan for managing blood sugar levels in adults with type 2 diabetes. The combination of sitagliptin and metformin hydrochloride works to improve glycemic control. This medication is often prescribed when diet and exercise alone are not enough to manage blood sugar levels effectively.

Common effects of Janumet XR 1000 mg/1 may include gastrointestinal discomfort, such as nausea or diarrhea, especially when first starting the medication. Some users may also experience headaches or a mild metallic taste. These effects are generally temporary and may subside as the body adjusts to the medication.

Janumet XR 1000 mg/1 should be taken exactly as prescribed by a healthcare provider. It is important to follow the recommended dosage and administration instructions. Patients should inform their healthcare provider about any other medications they are taking to avoid potential interactions. Regular monitoring of blood sugar levels is advised.

Janumet XR 1000 mg/1 may interact with certain medications, including those that affect kidney function or other diabetes medications. Alcohol consumption should be limited, as it can increase the risk of lactic acidosis. Patients should consult their healthcare provider before starting or stopping any medications while taking Janumet XR 1000 mg/1.